Energetic dysfunction and iron overload in early Parkinson's disease: Two distinct mechanisms?

Biomarkers Multiparametric magnetic resonance imaging Parkinson disease Synucleinopathies sodium

Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
06 May 2024
Historique:
received: 27 01 2024
revised: 09 04 2024
accepted: 30 04 2024
medline: 23 5 2024
pubmed: 23 5 2024
entrez: 22 5 2024
Statut: aheadofprint

Résumé

Identifying biomarkers reflecting cellular dysfunctions in early Parkinson's disease patients (ePD) is needed to develop targeted therapeutic strategies. We aimed to determine if cellular energetic dysfunction related to increased brain sodium concentration would be co-located to microstructural alterations and iron deposition in ePD. We prospectively included 12 ePD (mean disease duration 20.0 ± 10.2 months) and 13 healthy controls (HC), scanned with a 7 T Relative to HC, ePD showed significantly higher sodium concentration in left Substantia nigra (SN) pars reticulata (46.13 mM ± 3.52 vs 38.60 mM ± 6.10, p = 0.038), a subpart of the SN pars compacta (SNc) and ventral tegmental area, Putamen, Globus Pallidum external, accumbens nucleus and claustrum. Significantly increased QSM and R2* values, and decreased T In ePD, brain sodium accumulation was broad and dissociated from iron accumulation. As with iron accumulation, a sodium-related pathophysiological approach could lead to identifying potential new therapeutic agents and deserves further investigation.

Identifiants

pubmed: 38776725
pii: S1353-8020(24)01008-3
doi: 10.1016/j.parkreldis.2024.106996
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106996

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest No COI.

Auteurs

Stephan Grimaldi (S)

APHM, Hôpital Universitaire Timone, Department of Neurology and Movement Disorders, 264 rue Saint-Pierre, Marseille, France; APHM, Hôpital Universitaire Timone, CEMEREM, 264 rue Saint-Pierre, Marseille, France; Aix Marseille Univ, CRMBM, CNRS, 27 Bd Jean-Moulin, Marseille, France. Electronic address: stephan.grimaldi@ap-hm.fr.

Arnaud Le Troter (A)

APHM, Hôpital Universitaire Timone, CEMEREM, 264 rue Saint-Pierre, Marseille, France; Aix Marseille Univ, CRMBM, CNRS, 27 Bd Jean-Moulin, Marseille, France.

Mohamed Mounir El Mendili (MM)

APHM, Hôpital Universitaire Timone, CEMEREM, 264 rue Saint-Pierre, Marseille, France; Aix Marseille Univ, CRMBM, CNRS, 27 Bd Jean-Moulin, Marseille, France.

Hugo Dary (H)

APHM, Hôpital Universitaire Timone, CEMEREM, 264 rue Saint-Pierre, Marseille, France; Aix Marseille Univ, CRMBM, CNRS, 27 Bd Jean-Moulin, Marseille, France.

Jean-Philippe Azulay (JP)

APHM, Hôpital Universitaire Timone, Department of Neurology and Movement Disorders, 264 rue Saint-Pierre, Marseille, France.

Wafaa Zaaraoui (W)

APHM, Hôpital Universitaire Timone, CEMEREM, 264 rue Saint-Pierre, Marseille, France; Aix Marseille Univ, CRMBM, CNRS, 27 Bd Jean-Moulin, Marseille, France.

Jean-Philippe Ranjeva (JP)

APHM, Hôpital Universitaire Timone, CEMEREM, 264 rue Saint-Pierre, Marseille, France; Aix Marseille Univ, CRMBM, CNRS, 27 Bd Jean-Moulin, Marseille, France.

Alexandre Eusebio (A)

APHM, Hôpital Universitaire Timone, Department of Neurology and Movement Disorders, 264 rue Saint-Pierre, Marseille, France; Aix Marseille Univ, CNRS, Institut de Neurosciences de la Timone, 27 Bd Jean-Moulin Marseille, France.

Ludovic de Rochefort (L)

APHM, Hôpital Universitaire Timone, CEMEREM, 264 rue Saint-Pierre, Marseille, France; Aix Marseille Univ, CRMBM, CNRS, 27 Bd Jean-Moulin, Marseille, France.

Maxime Guye (M)

APHM, Hôpital Universitaire Timone, CEMEREM, 264 rue Saint-Pierre, Marseille, France; Aix Marseille Univ, CRMBM, CNRS, 27 Bd Jean-Moulin, Marseille, France.

Classifications MeSH